Vimarsana
Biggest News Aggregation in the World

Page 6 - Global External News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global External. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global External Today - Breaking & Trending Today

INVENTIVA: Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 25 May 2023 - Vimarsana News

INVENTIVA: Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 25 May 2023

Daix, 25 May 2023 Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l'Autorité des marchés financiers), the purpose of this description is to present the objectives and

INVENTIVA: Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China - Vimarsana News

INVENTIVA: Inventiva announces that its partner Sino Biopharm received IND approval from the NMPA to initiate clinical trial with lanifibranor in China

Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a Sino Biopharm's subsidiary, receives IND approval from the NMPA to initiate the clinical development in mainland China of lanifibranor in NASHSino Biopharm

Stock Market | FinancialContent Business Page - Vimarsana News

Stock Market | FinancialContent Business Page

FinancialContent fully hosted finance channel

INVENTIVA: Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update - Vimarsana News

INVENTIVA: Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update

Cash and cash equivalents at €56.3 million, short-term deposits at €0.7 million2, and long term deposit at €9.3 million3 as of March 31, 2023, compared to €86.7 million, €1.0 million and €0.7 million as

Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update - Vimarsana News

Inventiva reports 2023 First Quarter Financial Information¹ and provides a corporate update

Cash and cash equivalents at €56.3 million, short-term deposits at €0.7 million2, and long term deposit at €9.3 million3 as of March 31, 2023, compared to €86.7 million, €1.0... | May 16, 2023